Targeting patient recovery priorities in degenerative cervical myelopathy: design and rationale for the recede- myelopathy trial—study protocol

HIGHLIGHTS

• who: Benjamin Davies and collaborators from the Author , Department of Neurosurgery, Cambridge University, Cambridge, UK , Cambridge Clinical Trials Unit, Cambridge University Hospital, Cambridge, UK , Pharmacy Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK , Medical Statistician, NIHR Surgical Reconstruction and Microbiology Research Centre, Birmingham, UK , Edinburgh Medical School and Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK , Institute of Health Research, University of Exeter, Exeter, UK , International Spinal Research Trust, London, UK , Department of Neurosurgery, St George`s Hospital, London, UK , u200bMyelopathyu200borg, Cambridge, UK , Toronto Rehabilitation Institute, Toronto, Ontario, Canada , Department of Clinical Neurosciences, University . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.